← FDA DRUG APPROVALS

FDA NDA · NDA020079

METHOTREXATE SODIUM

Sponsor: EPIC PHARMA LLC

APPLICATION
NDA020079
TYPE
NDA
ORIGINAL APPROVAL
1991-11-27
LATEST ACTION
1996-04-16
ROUTE
IRRIGATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

METHOTREXATE SODIUMDiscontinued
CALCIUM CHLORIDE 0.154MG/ML, DEXTROSE 0.92MG/ML, GLUTATHIONE DISULFIDE 0.184MG/ML, MAGNESIUM CHLORIDE 0.2MG/ML, POTASSIUM CHLORIDE 0.38MG/ML, SODIUM BICARBONATE 2.1MG/ML, SODIUM CHLORIDE 7.14MG/ML, SODIUM PHOSPHATE 0.42MG/ML · SOLUTION · IRRIGATION

Approval history

1996-04-16Labeling · Supplement 3AP
1996-04-16Labeling · Supplement 2AP
1992-05-12Labeling · Supplement 1AP
1991-11-27Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →